IS
IS · IS · IS-EU/1/18/1296/001-002
Tegsedi
ATC N07XX15
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerAkcea Therapeutics Ireland Ltd
CountryIS (IS)
ATC codeN07XX15
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Stungulyf, lausn í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "N07XX15",
"marketed": false,
"strength": "284 mg",
"ma_number": "EU/1/18/1296/001-002",
"substance": "Inotersenum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í taugasjúkdómum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "43287"
}Related drugs
Other records sharing ATC code N07XX15.
- FITegsediAkcea Therapeutics Ireland Ltd
- PLTegsediAkcea Therapeutics Ireland Ltd.
- DKTegsediAkcea Therapeutics Ireland ltd
- CZTEGSEDIAkcea Therapeutics Ireland Ltd, Dublin
- CZTEGSEDIAkcea Therapeutics Ireland Ltd, Dublin
- NLTegsedi 189 mg/ml, oplossing voor injectie in voorgevulde spuitAkcea Therapeutics Ireland Ltd
- BETegsedi 284 mgAkcea Therapeutics Ireland
- GBTegsedi 284mg/1.5ml solution for injection pre-filled syringesSwedish Orphan Biovitrum Ltd
Access this data programmatically
Query Tegsedi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.